151 related articles for article (PubMed ID: 36786975)
1. Outcomes and risk factors in patients with crescentic glomerulonephritis: a multicenter cohort study.
Su X; Song R; Li S; Guo W; Guo X; Qiao X; Wang L
J Nephrol; 2023 May; 36(4):1027-1035. PubMed ID: 36786975
[TBL] [Abstract][Full Text] [Related]
2. The Outcome of Pauci-immune Crescentic Glomerulonephritis and Its Prognostic Factors; A single Center Case Series.
Najafi N; Ossareh S; Mehrazma M; Vahedi M
Iran J Kidney Dis; 2024 Jan; 1(1):9-17. PubMed ID: 38308546
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes in patients with biopsy-proved diabetic nephropathy compared to isolated lupus or crescentic glomerulonephritis.
Chou YH; Lin WC; Chen YM
Diabetes Res Clin Pract; 2019 Feb; 148():144-151. PubMed ID: 30641169
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in crescentic glomerulonephritis: a single-center experience.
Ozturk R; Yenigun EC; Dede F; Koc E; Turgut D; Piskinpasa SV; Ozkayar N; Odabas AR
Iran J Kidney Dis; 2015 Jan; 9(1):31-8. PubMed ID: 25599734
[TBL] [Abstract][Full Text] [Related]
5. Divergent manifestations and outcomes of diffuse crescentic immunoglobulin A nephropathy and pauci-immune crescentic glomerulonephritis on long-term.
Prasad N; Khurana M; Kushwaha R; Patel M; Bhaduaria D; Kaul A; Behera M; Yaccha M; Jain M; Agrawal V
Int Urol Nephrol; 2023 Jul; 55(7):1847-1855. PubMed ID: 36781681
[TBL] [Abstract][Full Text] [Related]
6. Clinical implication of crescentic lesions in immunoglobulin A nephropathy.
Lee MJ; Kim SJ; Oh HJ; Ko KI; Koo HM; Kim CH; Doh FM; Yoo TH; Kang SW; Choi KH; Lim BJ; Jeong HJ; Han SH
Nephrol Dial Transplant; 2014 Feb; 29(2):356-64. PubMed ID: 24081867
[TBL] [Abstract][Full Text] [Related]
7. Renal outcome and risk factors for end-stage renal disease in pediatric rapidly progressive glomerulonephritis.
Piyaphanee N; Ananboontarick C; Supavekin S; Sumboonnanonda A
Pediatr Int; 2017 Mar; 59(3):334-341. PubMed ID: 27542664
[TBL] [Abstract][Full Text] [Related]
8. Glomerular expression of C-C chemokines in different types of human crescentic glomerulonephritis.
Liu ZH; Chen SF; Zhou H; Chen HP; Li LS
Nephrol Dial Transplant; 2003 Aug; 18(8):1526-34. PubMed ID: 12897090
[TBL] [Abstract][Full Text] [Related]
9. A clinico-pathologic study of crescentic glomerulonephritis in 50 children. A report of the Southwest Pediatric Nephrology Study Group.
Kidney Int; 1985 Feb; 27(2):450-8. PubMed ID: 3887000
[TBL] [Abstract][Full Text] [Related]
10. Crescents proportions above 10% are associated with unfavorable kidney outcomes in IgA nephropathy patients with partial crescent formation.
Di D; Liu L; Wang Y; Yang Y; Jiang S; Li W
Ren Fail; 2023 Dec; 45(1):2226257. PubMed ID: 37357427
[TBL] [Abstract][Full Text] [Related]
11. Prognostic analysis of crescentic glomerulonephritis with acute kidney injury: a single-center cohort with 5-year follow-up.
Chen Z; Xu J; Wu J; Xue C; Ruan M; Mei C; Mao Z
Int Urol Nephrol; 2022 Sep; 54(9):2375-2383. PubMed ID: 35157218
[TBL] [Abstract][Full Text] [Related]
12. Etiology and Outcome of Crescentic Glomerulonephritis From a Single Center in China: A 10-Year Review.
Chen S; Tang Z; Xiang H; Li X; Chen H; Zhang H; Hu W; Zeng C; Liu Z
Am J Kidney Dis; 2016 Mar; 67(3):376-83. PubMed ID: 26388283
[TBL] [Abstract][Full Text] [Related]
13. The predictive value of kidney biopsy in renal vasculitis: a multicenter cohort study.
Diaz-Crespo F; Villacorta J; Acevedo M; Cavero T; Guerrero C; García Díaz E; Orradre JL; Martinez MA; Praga M; Fernandez-Juarez G
Hum Pathol; 2016 Jun; 52():119-27. PubMed ID: 26980047
[TBL] [Abstract][Full Text] [Related]
14. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
[TBL] [Abstract][Full Text] [Related]
15. C3 glomerulonephritis with a severe crescentic phenotype.
Ravindran A; Fervenza FC; Smith RJH; Sethi S
Pediatr Nephrol; 2017 Sep; 32(9):1625-1633. PubMed ID: 28593446
[TBL] [Abstract][Full Text] [Related]
16. Membranous nephropathy with crescents: a series of 19 cases.
Rodriguez EF; Nasr SH; Larsen CP; Sethi S; Fidler ME; Cornell LD
Am J Kidney Dis; 2014 Jul; 64(1):66-73. PubMed ID: 24709471
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of initial histology and effect of plasmapheresis on long-term prognosis of rapidly progressive glomerulonephritis.
Zäuner I; Bach D; Braun N; Krämer BK; Fünfstück R; Helmchen U; Schollmeyer P; Böhler J
Am J Kidney Dis; 2002 Jan; 39(1):28-35. PubMed ID: 11774098
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological characteristics and predictors of outcome of rapidly progressive glomerulonephritis: a retrospective study.
Mohamed ON; Ibrahim SA; Saleh RK; Issa AS; Setouhi A; Rabou AAA; Mohamed MR; Kamel SF
BMC Nephrol; 2024 Mar; 25(1):103. PubMed ID: 38500101
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic predictors of death and ESRD in patients with pauci-immune necrotizing glomerulonephritis.
Kapitsinou PP; Ioannidis JP; Boletis JN; Sotsiou F; Nakopoulou L; Daphnis E; Moutsopoulos HM
Am J Kidney Dis; 2003 Jan; 41(1):29-37. PubMed ID: 12500219
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive Treatment in C3 Glomerulopathy: Is it Really Effective?
Caliskan Y; Torun ES; Tiryaki TO; Oruc A; Ozluk Y; Akgul SU; Temurhan S; Oztop N; Kilicaslan I; Sever MS
Am J Nephrol; 2017; 46(2):96-107. PubMed ID: 28700996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
